Medacta Cash Conversion Cycle from 2010 to 2026

MOVE Stock   151.60  1.40  0.93%   
Medacta Group Cash Conversion Cycle yearly trend continues to be fairly stable with very little volatility. Cash Conversion Cycle will likely drop to 347.31 in 2026. During the period from 2010 to 2026, Medacta Group Cash Conversion Cycle regression line of quarterly data had mean square error of  825.12 and geometric mean of  426.86. View All Fundamentals
 
Cash Conversion Cycle  
First Reported
2010-12-31
Previous Quarter
402.42
Current Value
347.31
Quarterly Volatility
28.96883725
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Medacta Group financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medacta Group's main balance sheet or income statement drivers, such as Tax Provision of 9.6 M, Interest Income of 241.4 K or Depreciation And Amortization of 78.8 M, as well as many indicators such as Price To Sales Ratio of 6.38, Dividend Yield of 0.0054 or PTB Ratio of 12.45. Medacta financial statements analysis is a perfect complement when working with Medacta Group Valuation or Volatility modules.
  
This module can also supplement various Medacta Group Technical models . Check out the analysis of Medacta Group Correlation against competitors.
The evolution of Cash Conversion Cycle for Medacta Group SA provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Medacta Group compares to historical norms and industry peers.

Latest Medacta Group's Cash Conversion Cycle Growth Pattern

Below is the plot of the Cash Conversion Cycle of Medacta Group SA over the last few years. It is Medacta Group's Cash Conversion Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Medacta Group's overall financial position and show how it may be relating to other accounts over time.
Cash Conversion Cycle10 Years Trend
Slightly volatile
   Cash Conversion Cycle   
       Timeline  

Medacta Cash Conversion Cycle Regression Statistics

Arithmetic Mean427.85
Geometric Mean426.86
Coefficient Of Variation6.77
Mean Deviation20.43
Median436.07
Standard Deviation28.97
Sample Variance839.19
Range113
R-Value(0.28)
Mean Square Error825.12
R-Squared0.08
Significance0.28
Slope(1.60)
Total Sum of Squares13,427

Medacta Cash Conversion Cycle History

2026 347.31
2025 402.42
2024 447.14
2023 459.84
2022 429.97
2021 454.34
2020 459.43

About Medacta Group Financial Statements

Medacta Group investors use historical fundamental indicators, such as Medacta Group's Cash Conversion Cycle, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Medacta Group. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cash Conversion Cycle 402.42  347.31 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Medacta Stock Analysis

When running Medacta Group's price analysis, check to measure Medacta Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medacta Group is operating at the current time. Most of Medacta Group's value examination focuses on studying past and present price action to predict the probability of Medacta Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medacta Group's price. Additionally, you may evaluate how the addition of Medacta Group to your portfolios can decrease your overall portfolio volatility.